The FDA Additive Review Process: Backlog and Failure to Observe Statutory Deadline, Report 104-436, U.S. House of Representatives, 104th Congress, 1st Session.
Contributors: United States. Congress. House.
Language: eng
Notes: Shipping List #: 96-0229-M.

Shipping List Date: 03/29/96.